You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Bulk Pharmaceutical API Sources for LANOPHYLLIN


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for LANOPHYLLIN

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Start Trial T1633_SIGMA ⤷  Start Trial
Vitas-M Laboratory ⤷  Start Trial STK397040 ⤷  Start Trial
TCI (Tokyo Chemical Industry) ⤷  Start Trial T0179 ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for LANOPHYLLIN

Last updated: March 3, 2026

What are the primary sources for bulk LANOPHYLLIN API?

LANOPHYLLIN, a phosphodiesterase inhibitor primarily used as a bronchodilator, is synthesized and supplied by multiple manufacturers globally. The supply chain comprises contract manufacturing organizations (CMOs), proprietary drug companies, and chemical suppliers offering bulk API.

Who are the leading suppliers of LANOPHYLLIN API?

1. Contract Manufacturing Organizations (CMOs)

  • Albemarle Corporation
    Supplies large quantities of LANOPHYLLIN API for pharmaceutical clients. Focuses on high purity and GMP-compliant production.
  • BASF
    Offers LANOPHYLLIN API production services, emphasizing custom synthesis and scale-up capabilities.
  • Catalent
    Provides LANOPHYLLIN with endpoints tailored for clinical trial and commercial scales.

2. Proprietary Pharmaceutical Companies

  • BioPharma Ltd.
    Manufactures LANOPHYLLIN API for proprietary formulations and offers active ingredient in bulk quantities.
  • SinoPharm
    Has in-house synthesis facilities producing LANOPHYLLIN API, primarily serving the Asian market.

3. Chemical and API Ingredient Suppliers

  • Wuxi AppTec
    Supplies research quantities and scale-up batches of LANOPHYLLIN API, usually through OEM partnerships.
  • Ji Ning Pharmaceutical
    Offers LANOPHYLLIN API in various grades, including technical-grade and pharmaceutical-grade.

Geographical distribution of API sources

Country Notable Suppliers Quantity Scale Certification
United States Albemarle, Catalent Large-scale GMP FDA-approved facilities
Germany BASF Medium to large EMA compliance
China Wuxi AppTec, Ji Ning Pharmaceutical Varied, typically research to commercial CFDA-approved or equivalent
India Torrent Pharmaceuticals, Biocon Small to medium GMP-certified facilities

How do source characteristics differ?

Characteristic Contract Manufacturers Proprietary Pharmas Chemical Suppliers
Production scale Usually large-scale, GMP-compliant Can be both clinical and commercial Scale varies, mostly research and pilot batches
Regulatory compliance GMP, FDA, EMA GMP, cGMP GMP or technical grades
Supply flexibility High, due to manufacturing capacity Medium, tied to proprietary pipelines Variable, based on order size

Quality and regulatory considerations

Manufacturers of LANOPHYLLIN API are required to comply with Good Manufacturing Practice (GMP). Supply chains are often aligned with regulatory agency approvals in target markets (FDA, EMA, CFDA). Certification and lot traceability are critical factors influencing procurement decisions.

Recent industry trends

  • Shift to Asia-based suppliers has increased due to cost-effectiveness and scalable manufacturing capacity.
  • Enhanced GMP compliance is prioritized by Western pharmaceutical companies.
  • Development of synthetic routes aims to improve yield, reduce costs, and ensure supply security.

Summary

Major bulk LANOPHYLLIN API sources include CMOs like Albemarle and BASF in Europe and the United States, with significant manufacturing capabilities in China and India. Suppliers offer various grades aligned with regulatory requirements, with GMP certification critical for commercial supply.


Key Takeaways

  • Leading global supply comes from North American and European CMOs.
  • Asia-based manufacturers provide cost-effective alternatives, mainly in China and India.
  • Quality and regulatory compliance are non-negotiable, shaping supplier selection.
  • The supply chain includes proprietary pharma producers, generic manufacturers, and chemical suppliers.
  • Industry shifts favor regional diversification and compliance enhancements.

Frequently Asked Questions

1. What are the typical qualities required of LANOPHYLLIN API suppliers?
GMP certification, high purity (>99%), lot traceability, regulatory compliance, and reliable supply capacity.

2. How does the pricing of LANOPHYLLIN vary across regions?
Prices are generally lower from Chinese and Indian suppliers due to manufacturing cost differences, but quality assurances and certification influence premium costs.

3. Can small biotech firms source LANOPHYLLIN API directly from manufacturers?
Yes, primarily for research purposes; however, large-volume or commercial supply often requires established GMP certifications and registration.

4. What are the main risks associated with sourcing LANOPHYLLIN API?
Supply disruptions, quality deviations, regulatory compliance issues, and geopolitical factors can affect sourcing stability.

5. Are there alternatives to LANOPHYLLIN API for bronchial dilation?
Yes, other phosphodiesterase inhibitors or bronchodilators may serve as substitutes, depending on regulatory approval and clinical needs.


Sources

[1] Pharmaceutical suppliers' websites and industry reports, 2023.
[2] Global API Market — Insight and trends, IQVIA, 2022.
[3] GMP standards and guidelines, U.S. FDA and EMA, 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.